Emily Pond

Researchers studied the rates of COVID-19 infection and death, and assessed the effect of corticosteroids on outcomes, among patients with rare autoimmune rheumatic diseases.

The incidence rates of infection, cardiovascular events, and malignancies were compared between JAK vs TNF inhibitors use among patients with RA.

Researchers described the obstetric outcomes, based on COVID-19 vaccination status, in pregnant women with rheumatic and musculoskeletal diseases.

Researchers assessed the efficacy of rituximab and cyclophosphamide in the treatment of mixed connective tissue disease-related interstitial lung disease.

Researchers assessed the prevalence of prolonged COVID-19 symptom duration among patients with systemic autoimmune rheumatic diseases.

Investigators sought to find out if the psychiatric effects of the COVID-19 pandemic were more strongly pronounced in individuals with lower economic and personal capital.

Researchers investigated the seroreactivity of COVID-19 vaccination and adverse events among patients with systemic lupus erythematosus and rheumatoid arthritis.

Researchers sought to determine the outcomes among pediatric patients with rheumatic disease and COVID-19.

Researchers sought to determine whether patients with celiac disease are at increased risk for HBV infection despite having received HBV vaccination.

Researchers investigated HCV’s burden in 2020 and projected global burden for 2030.

Independent risk factors for pressure ulcers in ICU patients admitted with COVID-19 are identified from patient data.

Investigators assessed the impact of underlying comorbidities on the efficacy of fecal microbiota transplantation in children with recurrent Clostridioides difficile infection.

Study authors described antibody responses among patients with rheumatic and musculoskeletal diseases receiving immunosuppressant therapy 6 months after completing the COVID-19 vaccine series.

Investigators assessed the effects of intake of mother’s own milk vs pasteurized donor milk on postnatal outcomes in extremely preterm infants.

Investigators assessed the efficacy of a novel microbiome therapeutic, SER-109, for the treatment of recurrent C difficile infection.

A study assessed the risk for self-harm, overdose, and all-cause mortality in adolescents and young adults during the COVID-19 pandemic.

Investigators assessed the relationship between alcohol consumption and risk for Helicobacter pylori infection.

Investigators assessed the impact of maternal antibiotic administration timing on infant gut colonization in babies delivered via cesarean section.

Researchers conducted a survey to determine whether physicians can estimate patients’ out-of-pocket expenses, based on information about drug prices and patients’ insurance plans.

The American College of Rheumatology developed a report to summarize the current understanding of hydroxychloroquine/chloroquine toxicity and discuss areas for future research.

Investigators assessed the impact of mask wearing on perception of health during the COVID-19 pandemic.

Researchers assessed perceived COVID-19 risk for infections and outcomes, as well as shielding practices, among patients with rheumatoid arthritis (RA) during the pandemic.

Researchers evaluated the outcomes of COVID-19 in patients with rheumatoid arthritis vs the general population, and also explored the outcomes among patients with RA, stratified by sex, race, and medications.

Investigators assessed the safety profile and antiviral activity of the agent RO7049389 for the treatment of chronic hepatitis B virus infection.

Investigators examined the impact of D welbionis on metabolism and features of obesity in mice with diet-induced obesity and diabetes.

Investigators conducted a retrospective cohort study of chilblains as a possible cutaneous manifestation of COVID-19.

Investigators evaluated the relationship among Helicobacter pylori infection, atrophic gastritis, and chronic kidney disease.

This study examined the experience and attitudes of mental health care providers towards telehealth.

The study authors established an international registry for COVID-19-related dermatologic symptoms in April 2020.

The researchers aimed to identify COVID-19-related stressors associated with changes in alcohol consumption and binge drinking since the pandemic began.